I 
118TH CONGRESS 
2D SESSION 
H. R. 7183 
To prohibit Federal funds from being used to provide certain gender transition 
procedures to minors. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 1, 2024 
Mr. MCCORMICK (for himself, Mr. ALFORD, Mr. ALLEN, Mr. ARRINGTON, Mr. 
BIGGS, Ms. BOEBERT, Mr. BURLISON, Mr. CLINE, Mr. CLYDE, Mr. COL-
LINS, Mr. DUNCAN, Mr. SCOTT FRANKLIN of Florida, Mr. MIKE GARCIA 
of California, Mr. TONY GONZALES of Texas, Mr. GOODEN of Texas, Mr. 
GROTHMAN, Mr. HARRIS, Mrs. HARSHBARGER, Mr. JACKSON of Texas, 
Mr. KELLY of Mississippi, Mr. LAMBORN, Mrs. LUNA, Mrs. MILLER of 
Illinois, Mrs. MILLER of West Virginia, Mr. MOONEY, Mr. MOORE of Ala-
bama, Mr. MURPHY, Mr. NEHLS, Mr. NORMAN, Mr. OGLES, Mr. POSEY, 
Mr. ROUZER, Mr. AUSTIN SCOTT of Georgia, Mr. STEUBE, Ms. TENNEY, 
Mr. TIFFANY, Mr. TIMMONS, Mr. VAN DREW, Ms. VAN DUYNE, Mr. 
WEBER of Texas, Mr. BABIN, Mrs. LESKO, Mr. WILLIAMS of Texas, Mr. 
LOUDERMILK, and Mr. WESTERMAN) introduced the following bill; which 
was referred to the Committee on Energy and Commerce 
A BILL 
To prohibit Federal funds from being used to provide certain 
gender transition procedures to minors. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
20:57 Feb 06, 2024
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H7183.IH
H7183
ssavage on LAPJG3WLY3PROD with BILLS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Protecting Resources 
Of Taxpayers to Eliminate Childhood Transgender Sur-
geries Act of 2024’’ or the ‘‘PROTECTS Act of 2024’’. 
SEC. 2. PROHIBITING FEDERAL FUNDS FROM BEING USED 
TO PROVIDE CERTAIN GENDER TRANSITION 
PROCEDURES TO MINORS. 
(a) IN GENERAL.—Notwithstanding any other provi-
sion of law, no Federal funds may be used or otherwise 
made available to provide or refer for a specified gender 
transition procedure to an individual under the age of 18 
or to reimburse any entity for providing such a procedure 
to such an individual. 
(b) SPECIFIED GENDER TRANSITION PROCEDURE 
DEFINED.— 
(1) IN GENERAL.—For purposes of this para-
graph, except as provided in paragraph (2), the term 
‘‘specified gender transition procedure’’ means, with 
respect to an individual, any of the following when 
performed for the purpose of intentionally changing 
the body of such individual to no longer correspond 
to their sex: 
(A) Performing any surgery, including— 
(i) castration; 
(ii) orchiectomy; 
(iii) scrotoplasty; 
VerDate Sep 11 2014 
20:57 Feb 06, 2024
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H7183.IH
H7183
ssavage on LAPJG3WLY3PROD with BILLS
(iv) vasectomy; 
(v) hysterectomy; 
(vi) oophorectomy; 
(vii) ovariectomy; 
(viii) metoidioplasty; 
(ix) penectomy; 
(x) phalloplasty; 
(xi) vaginoplasty; 
(xii) vaginectomy; 
(xiii) vulvoplasty; 
(xiv) reduction thyrochondroplasty; 
(xv) chondrolaryngoplasty; 
(xvi) mastectomy; and 
(xvii) any plastic, cosmetic, or aes-
thetic 
surgery 
that 
feminizes 
or 
masculinizes the facial or other body fea-
tures of an individual. 
(B) Any placement of chest implants to 
create feminine breasts. 
(C) Any placement of fat or artificial im-
plants in the gluteal region. 
(D) Administering, supplying, prescribing, 
dispensing, distributing, or otherwise conveying 
to an individual medications, including— 
VerDate Sep 11 2014 
20:57 Feb 06, 2024
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H7183.IH
H7183
ssavage on LAPJG3WLY3PROD with BILLS
(i) 
gonadotropin-releasing 
hormone 
(GnRH) analogues or other puberty-block-
ing drugs to stop or delay normal puberty; 
and 
(ii) testosterone, estrogen, or other 
androgens to an individual at doses that 
are supraphysiologic than would normally 
be produced endogenously in a healthy in-
dividual of the same age and sex. 
(2) EXCEPTION.—Paragraph (1) shall not 
apply to the following when furnished to an indi-
vidual by a health care provider with the consent of 
such individual’s parent or legal guardian: 
(A) Puberty suppression or blocking pre-
scription drugs for the purpose of normalizing 
puberty for an individual experiencing pre-
cocious puberty. 
(B) Appropriate and medically necessary 
procedures or treatments to correct for— 
(i) a medically verifiable genetic dis-
order of sex development, including— 
(I) 46,XX chromosomes with 
virilization; 
(II) 46,XY chromosomes with 
undervirilization; and 
VerDate Sep 11 2014 
20:57 Feb 06, 2024
Jkt 049200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H7183.IH
H7183
ssavage on LAPJG3WLY3PROD with BILLS
(III) both ovarian and testicular 
tissue; 
(ii) sex chromosome structure, sex 
steroid hormone production, or sex hor-
mone action, if determined to be abnormal 
by a physician through genetic or bio-
chemical testing; or 
(iii) infection, disease, injury, or dis-
order caused or exacerbated by a previous 
procedure described in paragraph (1), or a 
physical disorder, physical injury, or phys-
ical illness that would, as certified by a 
physician, place the individual in imminent 
danger of death or impairment of a major 
bodily function unless the procedure is per-
formed, not including procedures per-
formed for the alleviation of mental dis-
tress. 
(3) SEX.—For purposes of paragraph (1), the 
term ‘‘sex’’ means the indication of male or female 
sex by reproductive potential or capacity, sex chro-
mosomes, naturally occurring sex hormones, gonads, 
or internal or external genitalia present at birth. 
Æ 
VerDate Sep 11 2014 
20:57 Feb 06, 2024
Jkt 049200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\H7183.IH
H7183
ssavage on LAPJG3WLY3PROD with BILLS